NP-301

NP-301 is a peptide-based therapeutic candidate being developed by Nano Intelligent Biomedical Engineering Corporation (NIBEC) for the treatment of periodontitis. It is designed as a long-acting local treatment, intended for topical or local administration to provide sustained therapeutic effects within the periodontal environment. Currently in the preclinical stage, NP-301 utilizes NIBEC's proprietary peptide technology to address the inflammatory and degenerative aspects of gum disease. The drug is engineered to provide prolonged therapeutic activity at the site of periodontal infection, although its specific molecular target has not been publicly disclosed in company pipeline materials.